Phase IIa study of RNS60 in multiple sclerosis initiated
Posted: Mon Nov 11, 2013 3:39 am
Revalesio Corporation has announced a new collaboration with noted neurologist Dr. Roland Martin, Head of Neuroimmunology and MS Research at the Department of Neurology, University Hospital Zurich. Dr. Martin will be conducting a Phase IIa clinical trial of RNS60 in patients with relapsing-remitting multiple sclerosis (RRMS or MS). With 30 years experience, Dr. Martin is a recognized leader in the field of neuroimmunology and multiple sclerosis research....... Read More - http://www.ms-uk.org/emergingtherapies